Work

Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient

Year: 2021

Type: article

Abstract: We discuss the case of a 74-year old male patient with mantle cell lymphoma, who faced severe CMV infection after the fifth cycle of first-line chemo-immunotherapy with a dose-reduced bendamustine and rituximab regimen.

Source: Mediterranean Journal of Hematology and Infectious Diseases

DOI: 10.4084/mjhid.2021.054

Authors: Gabriele Magliano, Annarosa Cuccaro, Francesco D'Alo', Elena Maiolo, Silvia Bellesi, Stefan Hohaus, Andrea Bacigalupo, Livio Pagano

Institutions: Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $647

OpenAlex ID: W3197042938

FWCI: 0.615

Cites: 13

Cited by: 4

Related to: 10